🇺🇸 FDA

Drug profile · INN

zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted)

ZOONOTIC INFLUENZA VACCINE SEQIRUS

J07BB02
Patents linked
0
News articles
0

Quick answer

zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted) (ZOONOTIC INFLUENZA VACCINE SEQIRUS) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted)
Brand ZOONOTIC INFLUENZA VACCINE SEQIRUS
ATC code J07BB02

Frequently asked questions

What is zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted)?

zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted) (ZOONOTIC INFLUENZA VACCINE SEQIRUS) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted)?

ZOONOTIC INFLUENZA VACCINE SEQIRUS is a marketed brand name for zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted). Check FDA Drugs@FDA for the current US label holder and prescribing information.